Generation of a Replication-competent, Propagation-deficient Virus Vector Based on the Transmissible Gastroenteritis Coronavirus Genome
Overview
Affiliations
Replication-competent propagation-deficient virus vectors based on the transmissible gastroenteritis coronavirus (TGEV) genome that are deficient in the essential E gene have been developed by complementation within E(+) packaging cell lines. Cell lines expressing the TGEV E protein were established using the noncytopathic Sindbis virus replicon pSINrep21. In addition, cell lines stably expressing the E gene under the CMV promoter have been developed. The Sindbis replicon vector and the ectopic TGEV E protein did not interfere with the rescue of infectious TGEV from full-length cDNA. Recombinant TGEV deficient in the nonessential 3a and 3b genes and the essential E gene (rTGEV-Delta3abDeltaE) was successfully rescued in these cell lines. rTGEV-Delta3abDeltaE reached high titers (10(7) PFU/ml) in baby hamster kidney cells expressing porcine aminopeptidase N (BHK-pAPN), the cellular receptor for TGEV, using Sindbis replicon and reached titers up to 5 x 10(5) PFU/ml in cells stably expressing E protein under the control of the CMV promoter. The virus titers were proportional to the E protein expression level. The rTGEV-Delta3abDeltaE virions produced in the packaging cell line showed the same morphology and stability under different pHs and temperatures as virus derived from the full-length rTGEV genome, although a delay in virus assembly was observed by electron microscopy and virus titration in the complementation system in relation to the wild-type virus. These viruses were stably grown for >10 passages in the E(+) packaging cell lines. The availability of packaging cell lines will significantly facilitate the production of safe TGEV-derived vectors for vaccination and possibly gene therapy.
Shah A, Esparza B, Illanes O, Hemida M Viruses. 2025; 17(2).
PMID: 40006964 PMC: 11861946. DOI: 10.3390/v17020209.
Mechanism, structural and functional insights into nidovirus-induced double-membrane vesicles.
Wang X, Chen Y, Qi C, Li F, Zhang Y, Zhou J Front Immunol. 2024; 15:1340332.
PMID: 38919631 PMC: 11196420. DOI: 10.3389/fimmu.2024.1340332.
Self-Replicating RNA Derived from the Genomes of Positive-Strand RNA Viruses.
Meyers G, Tews B Methods Mol Biol. 2024; 2786:25-49.
PMID: 38814389 DOI: 10.1007/978-1-0716-3770-8_2.
Negi K, Agarwal M, Pahuja I, Bhardwaj B, Rawat M, Bhaskar A Oxf Open Immunol. 2023; 4(1):iqad001.
PMID: 37051070 PMC: 9985161. DOI: 10.1093/oxfimm/iqad001.
mRNA Vaccines against SARS-CoV-2: Advantages and Caveats.
Echaide M, Chocarro de Erauso L, Bocanegra A, Blanco E, Kochan G, Escors D Int J Mol Sci. 2023; 24(6).
PMID: 36983017 PMC: 10051235. DOI: 10.3390/ijms24065944.